Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksFREDUN
resources
FREDUN

Fredun Pharmaceuticals Ltd.

BSE: 539730
Sector: Healthcare
Industry: Pharmaceuticals
1,434.60-36.9 (-2.51%)
21 Aug, 12:00 AM

Annual Reports and Financial Documents

Fredun Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls————————————
Presentations—————————————

Corporate Announcements and Regulatory Filings

Fredun Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General17 Aug 2026
    Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Exchange Of India Limited.
    Intimation regarding permission to trade and admission of Equity Shares to dealing on the National Stock Exchange of India
  2. Reg. 32 (1), (3) - Statement of Deviation & Variation14 Aug 2026
    Statement Of Deviation Or Variation For The Quarter Ended
    Statement of Deviation or Variation For the Quarter Ended June 30, 2026.
  3. Monitoring Agency Report14 Aug 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    Monitoring Agency Report dated 14.08.2026
  4. Analyst / Investor Meet13 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording Q1 FY27 'Earnings Conference Call' of Fredun Pharmaceuticals Limited.
  5. Analyst / Investor Meet8 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Earnings Conference Call for the quarter Q1 of FY27.
  6. Newspaper Publication6 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June, 2026
  7. Press Release / Media Release6 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Newspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June, 2026
  8. Press Release / Media Release6 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release issued by Fredun Pharmaceuticals Limited
  9. Outcome of Board Meeting5 Aug 2026
    Board Meeting Outcome for Outcome Of The Board Meeting
    In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the quarter ended ....
  10. Board Meeting30 Jul 2026
    Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Wednesday, 05Th August, 2026.
    Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Notice is hereby given ....
  11. Allotment of Equity Shares17 Jul 2026
    Announcement under Regulation 30 (LODR)-Allotment
    Allotment of Bonus Equity Shares.
  12. Record Date10 Jul 2026
    Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Issue Of Bonus Equity Shares.
    Intimation of Record Date pursuant to SEBI LODR Regulations, 2015 for Issue of Bonus Equity Shares.
  13. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018
  14. AGM30 Jun 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Scrutinizer''s Report for 39th Annual General Meeting.
  15. AGM30 Jun 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Outcome of 39th Annual General Meeting
  16. Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  17. Analyst / Investor Meet10 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of the Q4 and year ended for the FY26 'Earnings Conference Call'
  18. Newspaper Publication9 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Clipping- Information regarding 39th Annual General Meeting to be held on 30th June, 2026 through video conference/other audio visual means.
  19. General8 Jun 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").
    Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
  20. Record Date8 Jun 2026
    Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2025-26
    Intimation of Record Date for the purpose of Final Dividend for the Financial Year 2025-26

Frequently Asked Questions

Where can I download the annual report of Fredun Pharmaceuticals Ltd.?
Annual reports of Fredun Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Fredun Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Fredun Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Fredun Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Fredun Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Fredun Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Fredun Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Fredun Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Fredun Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Fredun Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Fredun Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Fredun Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Fredun Pharmaceuticals Ltd. is INE194R01017. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Fredun Pharmaceuticals Ltd. listed?
Fredun Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is FREDUN and the BSE code is -.
Where can I find the shareholding pattern of Fredun Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Fredun Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Fredun Pharmaceuticals Ltd. on Sharpely?
Share price data for Fredun Pharmaceuticals Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.